विवरण
Correlation analysis between gut microbiota changes and clinical symptom improvements in IBS-D participants receiving Lactiplantibacillus plantarum GTB1. The data suggest associations between specific bacterial genera and bowel symptom relief.
Figure 12
ChartSource Paper
Effect of Oral Intake of Lactiplantibacillus plantarum APsulloc 331261 (GTB1TM) on Diarrhea-Predominant Irritable Bowel Syndrome: A Randomized, Double-Blind, Placebo-Controlled Study.Cite This Figure
![Figure 12: Correlation analysis between gut microbiota changes and clinical symptom improvements in IBS-D participants receiving Lactiplantibacillus plantarum GTB1. The data suggest associations between specific bacterial genera and bowel symptom relief.]() > Source: Kyoungmi Jung et al. "Effect of Oral Intake of Lactiplantibacillus plantarum APsulloc 331261 (GTB1TM) ." *Nutrients*, 2022. PMID: [35631156](https://pubmed.ncbi.nlm.nih.gov/35631156/)
<figure> <img src="" alt="Correlation analysis between gut microbiota changes and clinical symptom improvements in IBS-D participants receiving Lactiplantibacillus plantarum GTB1. The data suggest associations between specific bacterial genera and bowel symptom relief." /> <figcaption>Figure 12. Correlation analysis between gut microbiota changes and clinical symptom improvements in IBS-D participants receiving Lactiplantibacillus plantarum GTB1. The data suggest associations between specific bacterial genera and bowel symptom relief.<br> Source: Kyoungmi Jung et al. "Effect of Oral Intake of Lactiplantibacillus plantarum APsulloc 331261 (GTB1TM) ." <em>Nutrients</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/35631156/">35631156</a></figcaption> </figure>